01

Dr. Reddy's Laboratories

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info : RX

Registration Country : USA

METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG;EQ 5MG BASE

Packaging :

Approval Date : 2023-08-09

Application Number : 207678

Regulatory Info : RX

Registration Country : USA

Product Web Link

02

Dr. Reddy's Laboratories

India

BioAsia

Hosting

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info : RX

Registration Country : USA

METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM;EQ 2.5MG BASE

Packaging :

Approval Date : 2023-08-09

Application Number : 207678

Regulatory Info : RX

Registration Country : USA

Product Web Link

03

Dr. Reddy's Laboratories

India

BioAsia

Hosting

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info : RX

Registration Country : USA

METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM;EQ 5MG BASE

Packaging :

Approval Date : 2023-08-09

Application Number : 207678

Regulatory Info : RX

Registration Country : USA

Product Web Link

04

Amneal Pharmaceuticals

U.S.A

BioAsia

Not Confirmed

05

Amneal Pharmaceuticals

U.S.A

BioAsia

Not Confirmed

06

AstraZeneca

United Kingdom

U.S.A

BioAsia

Not Confirmed

KOMBIGLYZE XR-1

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

20 API Suppliers

12 USDMF

6 EU WC

6 NDC API

5 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

62 FDF Dossiers

30 FDA Orange Book

23 Europe

9 Canada

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 BASF

1 Clariant

5 Corel Pharma Chem

6 DFE Pharma

7 Gangwal Chemicals

2 Ideal Cures

1 Ingredion Pharma Solutions

17 Kerry

3 Keval Exports

1 Kima Chemical

13 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

10 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Silverline Chemicals

1 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

31 Fillers, Diluents & Binders

20 Coating Systems & Additives

19 Direct Compression

16 Granulation

16 Thickeners and Stabilizers

15 Disintegrants & Superdisintegrants

12 Lubricants & Glidants

8 Co-Processed Excipients

8 Controlled & Modified Release

6 Film Formers & Plasticizers

5 Rheology Modifiers

3 Parenteral

3 Taste Masking

3 Solubilizers

3 Topical

3 Chewable & Orodispersible Aids

2 API Stability Enhancers

2 Emulsifying Agents

1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

11 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 2.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons